CareCloud (NASDAQ:CCLD) Updates FY 2026 Earnings Guidance

CareCloud (NASDAQ:CCLD) updated its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 0.200-0.230 for the period, compared to the consensus earnings per share estimate of 0.370. The company issued revenue guidance of $128.0 million-$132.0 million, compared to the consensus revenue estimate of $131.0 million.

CareCloud Price Performance

Shares of CareCloud stock traded down $0.17 during midday trading on Thursday, hitting $2.37. The company had a trading volume of 1,240,756 shares, compared to its average volume of 443,701. The stock has a market cap of $100.74 million, a PE ratio of 21.32 and a beta of 1.51. The business’s 50 day simple moving average is $2.29 and its two-hundred day simple moving average is $2.62. CareCloud has a 1-year low of $2.03 and a 1-year high of $4.01.

CareCloud (NASDAQ:CCLD) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.02 by $0.04. CareCloud had a return on equity of 24.05% and a net margin of 7.87%.CareCloud has set its FY 2026 guidance at 0.200-0.230 EPS. On average, sell-side analysts expect that CareCloud will post 0.36 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have commented on CCLD. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CareCloud in a report on Wednesday, June 24th. Wall Street Zen cut shares of CareCloud from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $3.25.

Hedge Funds Weigh In On CareCloud

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Essex Investment Management Co. LLC bought a new stake in CareCloud during the 4th quarter valued at $2,000,000. Geode Capital Management LLC boosted its stake in CareCloud by 235.4% during the 2nd quarter. Geode Capital Management LLC now owns 359,486 shares of the company’s stock valued at $848,000 after purchasing an additional 252,299 shares during the last quarter. Renaissance Technologies LLC boosted its position in shares of CareCloud by 96.1% during the fourth quarter. Renaissance Technologies LLC now owns 446,030 shares of the company’s stock valued at $1,302,000 after buying an additional 218,530 shares during the last quarter. Acadian Asset Management LLC grew its stake in shares of CareCloud by 481.9% in the 1st quarter. Acadian Asset Management LLC now owns 203,053 shares of the company’s stock worth $280,000 after acquiring an additional 168,156 shares in the last quarter. Finally, 683 Capital Management LLC purchased a new stake in CareCloud in the 4th quarter valued at about $467,000. 10.16% of the stock is owned by institutional investors and hedge funds.

CareCloud Company Profile

CareCloud, Inc is a healthcare technology company that provides cloud-based practice management, electronic health record (EHR) and revenue cycle management (RCM) solutions to medical practices and health systems. Its flagship offering, the CareCloud Central platform, combines clinical, financial and administrative workflows into a single, unified system. The platform includes modules for scheduling, billing, coding, patient engagement and telehealth, enabling practices to streamline front- and back-office operations and improve overall practice performance.

Founded in 2009 and headquartered in Miami Beach, Florida, CareCloud serves small to mid-size physician groups and specialty clinics across the United States.